INJECTION SITE BRUISING
Adverse reaction reported in 36,412 FDA reports across 15 drugs.
36,412
Total Reports
15
Drugs Involved
Etanercept
Most Reported Drug
Drugs Associated with INJECTION SITE BRUISING
Drugs where "INJECTION SITE BRUISING" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Etanercept | 13,738 | |
| 2 | Teriparatide | 4,768 | |
| 3 | Evolocumab | 4,632 | |
| 4 | Tirzepatide | 3,266 | |
| 5 | Dulaglutide | 1,930 | |
| 6 | Exenatide | 1,843 | |
| 7 | Glatiramer | 1,165 | |
| 8 | Somatropin | 1,076 | |
| 9 | Abaloparatide | 984 | |
| 10 | Alirocumab | 848 | |
| 11 | Galcanezumab-Gnlm | 684 | |
| 12 | Asfotase Alfa | 481 | |
| 13 | Interferon Beta-1b | 439 | |
| 14 | Peginterferon Beta-1a | 348 | |
| 15 | Pegvaliase-Pqpz | 210 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused injection site bruising. Always consult your healthcare provider.